Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE-Reference-Cited by-同舟云学术

Risk for Venous Thromboembolism Recurrence Among Rivaroxaban-treated Patients Who Continued Versus Discontinued Therapy: Analyses Among Patients with VTE

Published:2017-07 Issue:7 Volume:39 Page:1396-1408
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Khorana Alok A.,Berger Jeffrey S.,Wells Philip S.,Seheult Roger,Ashton Veronica,Laliberté François,Crivera Concetta,Lejeune Dominique,Schein Jeff,Wildgoose Peter,Lefebvre Patrick,Kaatz Scott

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference21 articles.

1. The epidemiology of venous thromboembolism;White;Circulation,2003

2. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors;Hansson;Arch Intern Med,2000

3. Natural history of venous thromboembolism;Kearon;Circulation,2003

4. Venous thromboembolism: risk factors for recurrence;Zhu;Arterioscler Thromb Vasc Biol,2009

5. The epidemiology of venous thromboembolism;Heit;J Thromb Thrombolysis,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Trends in the Duration of Anticoagulant Therapy for Venous Thromboembolism: A Systematic Review;Cureus;2021-10-23

2. Rivaroxaban treatment for young patients with pulmonary embolism (Review);Experimental and Therapeutic Medicine;2020-05-25

3. Rivaroxaban for the treatment of venous thromboembolism in real life;Medicine;2019-01

4. Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug–drug interactions;Critical Reviews in Oncology/Hematology;2018-12

5. Breadth of complications of long-term oral anticoagulant care;Hematology;2018-11-30